3 Item 1A. Risk Factors 21 Item 1B. Unresolved Staff Comments 70 Item 1C. Cybersecurity 70 Item 2. Properties 71 Item 3. Legal Proceedings 71 Item 4. Mine Safety Disclosures 71 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 72 Item 6. [Reserved] 72 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 73 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 81 Item 8....
Q2 FY2026 — expected 2026-08-09
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-26 | 2025-12-31 | 0001193125-26-126371 | EDGAR | 104K words |
| 2025-03-27 | 2024-12-31 | 0000950170-25-046096 | EDGAR | — |
| 2024-03-27 | 2023-12-31 | 0000950170-24-037160 | EDGAR | — |
| 2023-03-31 | 2022-12-31 | 0000950170-23-011133 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0000950170-22-005203 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0001564590-21-016996 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-14 | 2025-09-30 | 0001193125-25-283169 | EDGAR | 29K words |
| 2025-08-14 | 2025-06-30 | 0001193125-25-180899 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0000950170-25-071635 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0000950170-24-126766 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0000950170-24-097022 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0000950170-24-060579 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0000950170-23-063713 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0000950170-23-042389 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0000950170-23-021974 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0000950170-22-025011 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0000950170-22-017140 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0000950170-22-010085 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-26 | 0001193125-26-126322 | EDGAR | 3K words |
| 2025-12-19 | 0001193125-25-326916 | EDGAR | — |
| 2025-11-21 | 0001193125-25-291443 | EDGAR | — |
| 2025-11-20 | 0001193125-25-289768 | EDGAR | — |
| 2025-11-14 | 0001193125-25-283075 | EDGAR | — |
| 2025-08-14 | 0001193125-25-180889 | EDGAR | — |
| 2025-06-30 | 0001193125-25-152767 | EDGAR | — |
| 2025-05-14 | 0001193125-25-119939 | EDGAR | — |
| 2025-04-14 | 0001193125-25-079656 | EDGAR | — |
| 2025-03-27 | 0001193125-25-065511 | EDGAR | — |
117 total filings indexed. 89 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001750149 |
| Ticker | IKT |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.inhibikase.com |
| Listed | 2020-12-23 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report